Allspring Global Investments Holdings, LLC Catalyst Pharmaceuticals, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $59.3 Billion
- Q4 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 417,332 shares of CPRX stock, worth $9.04 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
417,332
Previous 366,444
13.89%
Holding current value
$9.04 Million
Previous $7.28 Million
19.56%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding CPRX
# of Institutions
346Shares Held
98.4MCall Options Held
13.4KPut Options Held
11.7K-
Black Rock Inc. New York, NY18.7MShares$405 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$183 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$126 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$67.9 Million1.62% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.01MShares$65.3 Million0.02% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.23B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...